Apellis Pharmaceuticals, Inc. — SCHEDULE 13G Filings
3 SCHEDULE 13G filings on record
This page lists all SCHEDULE 13G filings submitted to the SEC by Apellis Pharmaceuticals, Inc. (APLS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Apellis Pharmaceuticals, Inc. has filed 3 SCHEDULE 13G documents with the SEC since 2019. To view all SEC filings by Apellis Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
144/A
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-K
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
POSASR
RW
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0001493215-26-000026 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0002012383-26-000899 | Feb 6, 2026 | — |
| SCHEDULE 13G | — | 0001172661-25-002414 | May 16, 2025 | — |